Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
21.20
-0.14 (-0.66%)
At close: Jul 31, 2026, 4:00 PM EDT
21.13
-0.07 (-0.33%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $219.54 million as of July 31, 2026. Its market cap has increased by 295.76% in one year.
Market Cap
219.54M
Enterprise Value
267.54M
1-Year Change
295.76%
Ranking
Category
Stock Price
$21.20
ChartMarket Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $219.54M, a decrease of -34.72%. That is a compound annual growth rate of -7.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 219.54M | 305.82% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Personalis | 1.29B |
| Freenome | 1.13B |
| OPKO Health | 996.35M |
| Castle Biosciences | 812.54M |
| Fulgent Genetics | 573.98M |
| Myriad Genetics | 507.19M |
| Insight Molecular Diagnostics | 148.53M |
| Exagen | 112.83M |